Health Trials

Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis

2

Review clinical trials related to Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.

Participants needed: 1,350
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: 89bio, Inc.Updated: Jul 13, 2026Locations: 361
Eligibility criteria

Males or non-pregnant females aged between 18 and 80 years (inclusive) at time o... [+2]

Chronic liver diseases other than MASH [+4]

Read more
Status: Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.

Participants needed: 1,350
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: 89bio, Inc.Updated: Jun 4, 2026Locations: 349
Eligibility criteria

Males or non-pregnant females aged between 18 and 80 years (inclusive) at time o... [+2]

Chronic liver diseases other than MASH [+4]

Read more